23/02/201826/01/2024 L-DOS47 US Phase I Study Presentation at the IASLC 18th Annual Target Therapies of Lung Cancer Meeting admin 0 Comments
22/02/201826/01/2024 Helix BioPharma Corp. Appoints Deloitte as Strategic Advisor to Explore Partnering and Licensing Opportunities admin 0 Comments
06/02/201826/01/2024 Helix BioPharma Corp and Helix Immuno-Oncology to present at AACR in Chicago admin 0 Comments
05/01/201826/01/2024 Helix BioPharma Corp. to Present at the Biotech Showcase Conference admin 0 Comments
04/01/201826/01/2024 Helix BioPharma Corp. Signs Binding Letter of Intent for Development of New CAR-T Technologies admin 0 Comments
13/12/201726/01/2024 Helix BioPharma Corp. Announces Fiscal First Quarter 2018 Results admin 0 Comments
12/12/201726/01/2024 Helix BioPharma Corp. Announces Voting Results From Annual and Special Meeting of Shareholders admin 0 Comments
27/10/201726/01/2024 Helix BioPharma Corp. Announces Fiscal 2017 Year-End Results and Provides Research and Development Program Update admin 0 Comments